Inspira Technologies OXY B.H.N. Ltd — Investor Relations & Filings

Inspira Technologies OXY B.H.N. Ltd. is a medical technology company focused on the research, development, and marketing of innovative life support and respiratory treatment systems. The company's portfolio includes the INSPIRA™ ART100, a system cleared by the U.S. Food and Drug Administration for cardiopulmonary bypass and Extracorporeal Membrane Oxygenation (ECMO) procedures. Its flagship product in development, the INSPIRA™ ART500, is an Augmented Respiration Technology system designed as an alternative to mechanical ventilation. This system aims to elevate and stabilize decreasing oxygen saturation levels by directly oxygenating small volumes of blood, potentially allowing patients to remain awake and avoiding the complications associated with invasive intubation.